A meta-analysis of 13 studies showed that patients who underwent sentinel node biopsy had a significantly reduced risk of death from melanoma. In addition, an analysis of nine studies showed that the ...
Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...
Findings from a phase 1/2 trial (NCT04176) presented at the 2025 American Society of Hematology Annual Meeting and Exposition ...
New ASH guidelines outline optimal management for a subgroup of patients with leukemia that historically has been challenging to treat.Two papers published simultaneously in Blood Advances address ...
As previously presented, gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and gedatolisib + fulvestrant (“gedatolisib doublet”) reduced the risk of disease progression or death versus ...
Richard Ingram, MD, FASCO, is president of the Virginia Association of Hematology and Oncology and a member of the Community ...
MaaT Pharma (EURONEXT: MAAT ? the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for ...
Study marks the first positive Phase 3 study for mezigdomide and the second positive Phase 3 study for the Bristol Myers Squibb CELMoD programPRINCETON, N.J.--(BUSINESS WIRE)--$BMY #CELMoD--Bristol ...
What should oncology nurses and advanced practice providers understand about GLP-1 RAs in the care of patients with breast ...
Everyday Health on MSN
How to manage LEMS weakness while treating lung cancer
Learn how to tell the difference between these two common symptoms.
A large analysis from the Global Burden of Disease collaborators projects that annual female breast cancer cases could climb from roughly 2.3 million in 2023 to about 3.56 million by 2050, with deaths ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results